Strongyloides Hyperinfection Syndrome among COVID-19 Patients Treated with Corticosteroids

Widespread use of corticosteroids for COVID-19 treatment has led to Strongyloides reactivation and severe disease in patients from endemic areas. We describe a US patient with COVID-19 and Strongyloides hyperinfection syndrome and review other reported cases. Our findings highlight the need for Stro...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jani M., Sivasubramanian, Geetha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239863/
https://www.ncbi.nlm.nih.gov/pubmed/35731220
http://dx.doi.org/10.3201/eid2807.220198
_version_ 1784737404964306944
author Kim, Jani M.
Sivasubramanian, Geetha
author_facet Kim, Jani M.
Sivasubramanian, Geetha
author_sort Kim, Jani M.
collection PubMed
description Widespread use of corticosteroids for COVID-19 treatment has led to Strongyloides reactivation and severe disease in patients from endemic areas. We describe a US patient with COVID-19 and Strongyloides hyperinfection syndrome and review other reported cases. Our findings highlight the need for Strongyloides screening and treatment in high-risk populations.
format Online
Article
Text
id pubmed-9239863
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-92398632022-07-06 Strongyloides Hyperinfection Syndrome among COVID-19 Patients Treated with Corticosteroids Kim, Jani M. Sivasubramanian, Geetha Emerg Infect Dis Research Letter Widespread use of corticosteroids for COVID-19 treatment has led to Strongyloides reactivation and severe disease in patients from endemic areas. We describe a US patient with COVID-19 and Strongyloides hyperinfection syndrome and review other reported cases. Our findings highlight the need for Strongyloides screening and treatment in high-risk populations. Centers for Disease Control and Prevention 2022-07 /pmc/articles/PMC9239863/ /pubmed/35731220 http://dx.doi.org/10.3201/eid2807.220198 Text en https://creativecommons.org/licenses/by/4.0/Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research Letter
Kim, Jani M.
Sivasubramanian, Geetha
Strongyloides Hyperinfection Syndrome among COVID-19 Patients Treated with Corticosteroids
title Strongyloides Hyperinfection Syndrome among COVID-19 Patients Treated with Corticosteroids
title_full Strongyloides Hyperinfection Syndrome among COVID-19 Patients Treated with Corticosteroids
title_fullStr Strongyloides Hyperinfection Syndrome among COVID-19 Patients Treated with Corticosteroids
title_full_unstemmed Strongyloides Hyperinfection Syndrome among COVID-19 Patients Treated with Corticosteroids
title_short Strongyloides Hyperinfection Syndrome among COVID-19 Patients Treated with Corticosteroids
title_sort strongyloides hyperinfection syndrome among covid-19 patients treated with corticosteroids
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239863/
https://www.ncbi.nlm.nih.gov/pubmed/35731220
http://dx.doi.org/10.3201/eid2807.220198
work_keys_str_mv AT kimjanim strongyloideshyperinfectionsyndromeamongcovid19patientstreatedwithcorticosteroids
AT sivasubramaniangeetha strongyloideshyperinfectionsyndromeamongcovid19patientstreatedwithcorticosteroids

Ejemplares similares